Sentien Co-Founder Dr. Biju Parekkadan to Speak at American Society of Gene & Cell Therapy Annual Meeting on 4/29
April 29, 2019 Event
Sentien Biotechnologies Scientific Co-Founder, Dr. Biju Parekkadan, will be speaking at the American Society of Gene & Cell Therapy Annual Meeting on April 29, 2019 in Washington, DC. He will be discussing Reprogramming Human Immune Responses Using Ex Vivo MSC Bioreactor Therapy.
Dr. Chris Gemmiti will be attending Phacilitate at the Hyatt Regency in Miami this January. Please reach out to schedule a time to meet with him and learn more about the Sentien approach. SCHEDULE A MEETING >
Meet with us at the 2019 J.P. Morgan Healthcare Conference
January 7-10, 2019 Event San Francisco, CA
The Sentien team will be attending the 2019 J.P. Morgan Healthcare Conference. This event continues to be one of the life science industry’s largest conferences of the year. Contact us today to schedule a time to meet with our team and learn more about our business. SCHEDULE A MEETING >